Gabriel Douville

Gabriel joined Sectoral in 2021 as Principal – Private Equity. He is responsible for supporting research and conducting in depth due diligence reviews on companies for the NEMO strategy.

Gabriel graduated in 2009 from McGill University with a B.Sc. in Biology, in 2013 from Université Laval with an M.Sc. in Animal Sciences and in 2018 from the University of New South Wales in Sydney with an MBA degree.

Prior to joining Sectoral, he worked as an Investment Associate at OneVentures in Sydney, investing in medtech and biopharma. He was an observer on the boards of BiVACOR, Madorra and Kira Biotech. Before completing his MBA, he was a Senior Sales Representative for Shire Pharmaceuticals’ Neuroscience franchise in Montreal (acquired by Takeda). He started his career at Paladin Labs as a Sales Representative for their Allergy and Immunology as well as their primary care portfolios, covering both Quebec and Ontario.